AMGN vs EGHT · P/E 24, rev $36.75B vs P/E 182, rev $715.1M
Amgen Inc (AMGN) versus 8x8 Inc Common Stock (EGHT) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
8x8 Inc Common Stock (EGHT) is a software - application company listed on NASDAQ.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported EGHT revenue for 2025-03-31 was $715.1M. Net income was -$27.2M. Revenue was down 1.9% from 2024-03-31 to 2025-03-31. EGHT currently screens at market cap $257.0M and trailing P/E 182.0.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. EGHT currently screens at market cap $257.0M and trailing P/E 182.0.
Not investment advice. Open the AMGN and EGHT stock pages for the full models.
Not investment advice.